Denosumab (Prolia)

DRUG5 trials

Sponsors

Rudolf Wuethrich, James J. Peters Veterans Affairs Medical Center, Martin Blomberg Jensen, Marmara University, Prince of Wales Hospital, Shatin, Hong Kong

Conditions

Chronic Kidney DiseaseInfertility, MaleOsteoporosisOsteoporosis in Post-menopausal WomenSarcopenia in ElderlySecondary OsteoporosisSpinal Cord Injury

Phase 1

NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia

Active, not recruitingNCT06706414

Martin Blomberg JensenInfertility, Male

Start: 2025-03-01End: 2026-08-01Target: 16Updated: 2026-04-17

Phase 3

Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients

CompletedNCT01377467

Rudolf WuethrichChronic Kidney Disease, Osteoporosis

Start: 2011-06-30End: 2015-10-31Updated: 2016-05-26

RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients

Not yet recruitingNCT07056478

Prince of Wales Hospital, Shatin, Hong KongSarcopenia in Elderly

Start: 2027-01-01End: 2030-01-01Target: 130Updated: 2026-09-16

Phase 4

The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury

TerminatedNCT03029442

James J. Peters Veterans Affairs Medical CenterSecondary Osteoporosis, Spinal Cord Injury

Start: 2017-04-01End: 2022-10-06Updated: 2024-03-15

Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures

Not yet recruitingNCT06720350

Marmara UniversityOsteoporosis in Post-menopausal Women

Start: 2025-01-15End: 2026-12-15Target: 60Updated: 2024-12-27

Related Papers

Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients.

2016-09-1412 citations